Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Add The Renewables Infrastructure Group Limited (TRIG) by Roland Head in The Motley Fool
- Avoid Prudential (PRU) by Mark David Hartley in The Motley Fool
- Avoid Shell (SHEL) by Royston Wild in The Motley Fool
- Buy Rio Tinto (RIO) by Royston Wild in The Motley Fool
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Avoid Heiq (HEIQ) by Steve Moore in ShareProphets
- Buy Shell (SHEL) by LBBW
- Buy PayPoint (PAY) by Jefferies
- Avoid ActiveOps (AOM) by Steve Moore in ShareProphets
- Watch Land Securities Group (LAND) by Alan Oscroft in The Motley Fool
- Watch Beazley (BEZ) by Harvey Jones in The Motley Fool
- Hold Land Securities Group (LAND) by Jefferies
- Watch Alliance Witan (ALW) by James Beard in The Motley Fool
- Buy Intermediate Capital Group (ICG) by Bank of America
- Hold GSK (GSK) by Deutsche Bank
- Neutral Experian (EXPN) by Citi
- Neutral Aviva (AV.) by Citi
- Neutral Smith (DS) (SMDS) by UBS
- Hold JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
- Strong Buy Taylor Wimpey (TW.) by Harvey Jones in The Motley Fool
LungLife AI, Inc (DI) (Reg S, Cat 3) (LLA) Share Price
NOTE: This is based on 0 open tips for LungLife AI, Inc (DI) (Reg S, Cat 3) (LLA)
| Latest Bid : 10.00p | Latest Ask : 20.00p |
| High Today : 15.00p | Low Today : 15.00p |
| This Years High : 30.00p | This Years Low : 15.00p |
| Volume : 0 | MKT Cap : £0.75M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
LungLife AI, Inc (DI) (Reg S, Cat 3) (LLA) Overview
LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.LungLife AI, Inc (DI) (Reg S, Cat 3) (LLA) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10.00p | Latest Ask : 20.00p |
| High Today : 15.00p | Low Today : 15.00p |
| This Years High : 30.00p | This Years Low : 15.00p |
| Volume : 0 | MKT Cap : £0.75M |
LungLife AI, Inc (DI) (Reg S, Cat 3) Overview
LungLife is a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence ("AI"). Lung cancer is one of the most lethal cancers, accounting for nearly a quarter of all cancer-related deaths in the US, and its global incidence has increased by 37 per cent. from 2007-2017. The Company's diagnostic solutions are designed to make significant improvements in the early detection of lung cancer.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.